Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1995, 618-619, Vol 33, No. 3
L Kaufman, AS Sekhon, N Moledina, M Jalbert and D Pappagianis
A total of 409 serum and cerebrospinal fluid specimens from human subjects
with proven coccidioidomycosis, with other infections, or with no apparent
illness were tested for antibodies to Coccidioides immitis by the Premier
EIA (Meridian Diagnostics, Inc., Cincinnati, Ohio), which tests for
immunoglobulin G (IgG) and IgM responses to coccidioidal antigens, and by
the conventional complement fixation (CF) or immunodiffusion (ID) assays
for antibodies corresponding to those detected by the tube precipitin (TP)
or CF tests. Of the 409 specimens, 47 were from persons with confirmed
coccidioidomycosis and all were positive for C. immitis antibodies in IDCF
tests and enzyme immunoassays (EIAs) for both IgG and IgM. The EIA for
detecting both IgG and IgM antibodies proved to be sensitive for detecting
coccidioidomycosis case sera positive by the IDCF, IDTP, and CF tests.
Maximal sensitivity for diagnosing coccidioidomycosis is dependent upon
detection of both IgG and IgM antibodies in the EIA. The EIA, however, was
not absolutely specific, since some sera from patients with confirmed
blastomycosis and some from patients with noncoccidioidal disease produced
false-positive reactions.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies
Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|